Mirtazapine
NDC 50090-1019
Product Information
Mirtazapine is a ANDA-approved product labeled by A-s Medication Solutions. Mirtazapine is used to treat depression. It is supplied as a yellow product. This product entry covers the primary NDC 50090-1019 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
APO;MI;15
Code Structure Chart
Product Details
What is NDC 50090-1019?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MIRTAZAPINE (UNII: A051Q2099Q)
- MIRTAZAPINE (UNII: A051Q2099Q) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)
- HYDROXYPROPYL METHYLCELLULOSE (UNII: 3NXW29V3WO)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- PEG-180 (UNII: Q662QK8M3B)
- CI 77891 (UNII: 15FIX9V2JP)
- HEMATITE (UNII: 1K09F3G675)
- CI 77492 (UNII: EX438O2MRT)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 311725 - mirtazapine 15 MG Oral Tablet
- RxCUI: 314111 - mirtazapine 30 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.